Atossa Therapeutics Adjourns Special Stockholder Meeting to October 7, 2021 to Allow Additional Time to Vote

NEXT STORY
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
PREV STORY
Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma Brain Cancer

NBTS provides $750,000 award to the Global Coalition for Adaptive Research to help launch ...

author_avatar
NASDAQ Market News

Ehave, Inc. To Acquire Mdlink The Largest Telemedicine Platform in The CARICOM Countries And To Launch Mdlink Mental Therapy along with Psychedelic Treatments To Address Mental Health

author_avatar
NASDAQ Market News

Provectus Biopharmaceuticals Announces Release of Preprint Manuscript Describing Preclinical Study of PV-10® Immunotherapy and Chemotherapy for Treatment of Pancreatic Cancer

author_avatar
NASDAQ Market News